ArticleThe Lancet regional health. Europe2022

Importance of predicting non-response to intravenous immunoglobulin therapy in non-Asian patients with Kawasaki disease.

Isabelle Koné-Paut et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.